CNS Pharmaceuticals, Inc.

( )
CNSP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 1.03%147.150.7%$941.74m
PFEPfizer Inc. 0.58%36.270.9%$897.36m
MRKMerck & Co., Inc. 1.13%83.890.7%$700.40m
ABBVAbbVie, Inc. 1.35%87.371.9%$686.13m
BMYBristol-Myers Squibb Co. 0.79%59.971.0%$642.93m
LLYEli Lilly & Co. 0.10%150.411.1%$562.34m
AZNAstraZeneca Plc -0.83%55.051.2%$255.60m
NVSNovartis AG 0.54%87.600.2%$164.80m
GSKGlaxoSmithKline Plc 0.19%37.870.2%$109.38m
PRNBPrincipia Biopharma, Inc. 0.00%100.050.0%$86.76m
NVONovo Nordisk A/S 0.03%69.060.1%$57.66m
RGENRepligen Corp. 0.00%144.307.1%$49.54m
SNYSanofi 0.87%51.220.2%$49.42m
RPRXRoyalty Pharma Plc 0.45%40.250.2%$47.22m
OPKOPKO Health, Inc. 1.55%3.2711.2%$44.24m

Company Profile

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.